A team of researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia (ALL), the most common type of childhood cancer.
Abcodia announced this week it raised $8 million to bring its ovarian cancer screening test called ROCA to market.
A new genetic test to determine risk factors for prostate cancer can help target the men most likely to develop aggressive forms for the cancer – and make screening a priority for them, according to research presented yesterday at the American Urology Association’s annual conference.
A tiny microfluidic chip can capture circulating clusters of tumor cells, researchers said. The finding could provide important new clues about how cancer spreads – and could even be a “breakthrough technology,” they said.
The hope is that this standard can be used among the scientific community to see how well their genomic analysis tools match up.
ABC News featured an interview with Julie Fitzgerald, a mom who noticed a white glow in her son Avery’s eye after taking a picture of him with her smartphone.
For the first time, a large study suggests that a vitamin might modestly lower the risk of the most common types of skin cancer in people with a history of these relatively harmless yet troublesome growths.
Researchers have identified new molecules that kill cancer cells while protecting healthy cells and that could be used to treat a variety of different cancers. The research shines a light on what happens to cells at the moment they become cancerous.
Standard versions of this screening process would have only been able to pinpoint ovarian cancer in less than half of this group.
It has been hailed as the equivalent of Google Maps for the human body by The New York Times, and now the award-winning mobile-friendly platform BioDigital Human is looking to change the way healthcare information is shared, consumed and understood.
A new type of blood test is starting to transform cancer treatment, sparing some patients the surgical and needle biopsies long needed to guide their care.
Watson, the supercomputer seen on Jeopardy, will play an important role in this partnership.
The translation of extracellular vesicle research to the clinic to aid in the diagnosis and treatment of many disease types will require the development of standard assays for their characterization and quantification. The challenge of such analysis lies in the submicron size (generally 50-1000 nm in diameter) of each vesicle, as well as the complexity of the biofluids in which they are typically suspended.
A new treatment for melanoma could be on the horizon. The authors of a new study report that they found high levels of an enzyme in melanoma samples that they believe is a potential drug target.
Polish surgeons said Monday they have successfully performed a rare and extensive transplant of the throat area.
A distinct pattern in the changing length of blood telomeres, the protective end caps on our DNA strands, can predict cancer many years before actual diagnosis, according to a new study.
Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk of death from the disease, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Stem cells, which have the potential to turn into any kind of cell, offer the tantalizing possibility of generating new tissues for organ replacements, stroke victims and patients of many other diseases. Now, scientists have uncovered details about stem cell growth that could help improve regenerative therapies.
The new experimental assay can help scientists find the precise locations of repair of DNA damage caused by UV radiation and common chemotherapies. The invention could lead to better cancer drugs or improvements in the potency of existing ones.
A mouse’s T cells can be primed to attack and eliminate a malignant tumor by injecting antibodies from another mouse with resistance to the tumor, as well as by activating certain signaling cells, a study has found.
The test can assess the risk for breast and ovarian cancer.
A team from Johannes Gutenberg University engineered a relatively cheap, and comparatively easy-to-make, personalized vaccine—and wiped out lung, skin, and colon cancer cells in mice.
ResearchKit is being touted as having immense implications for the future of clinical trials.
A new study has discovered the trigger behind the most severe forms of cancer pain.